Key facts
- ViXion’s last known valuation is $26.0M (Aug 2022).
- It has raised $8.3M; the latest was Early Stage VC in May 2025.
- Notable investors include Senju Pharmaceutical, Exedy, Exedy Company, Pilot (), Pilot (Tokyo) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for ViXion
- ·The full record, as it builds
Funding rounds
No funding rounds for ViXion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ViXion
Developer of a wearable device intended to help those who have trouble seeing in the dark or brighter vision. The company's device has a built-in low-light, high-sensitivity compact camera that amplifies a small amount of light and captures images in natural colors, enabling visually impaired and ophthalmic patients to improve and support their vision.
- Sector
- Information Technology
- HQ
- Tokyo, Japan
- Founded
- 2021
- Employees
- 11
- Website
- vixion.jp/
- Ownership
- Privately Held (backing)
ViXion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ViXion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ViXion in its N-PORT filings yet. We sweep new filings monthly.